IFRA updates industry code
This article was originally published in The Rose Sheet
Executive Summary
International Fragrance Association's 45 amendment to its Code of Practice contains seven changes: new standards for dimethylcyclohex-3-ene-1-carbaldehyde (mixed isomers), alpha-methyl-1,2-benzodioxole-5-propionaldehyde (MMDHCA) and 3-phenylbutanal; one revised standard for verbena absolute (Lippia citriodora Kunth.); one revised standard for 2,2-dimethyl-3-(3-tolyl)propan-1-ol (majantol); one new specification standard for musk ketone; and one new prohibition on quinoline, an aromatic organic compound. As expected, the amendment was "light" compared with previous years, as organization's changeover to dermal sensitization Quantitative Risk Assessment approach has been completed (1"The Rose Sheet" June 7, 2010, In Brief)
You may also be interested in...
IFRA's upcoming amendment "very light"
The International Fragrance Association's 45 Amendment to its Code of Practice, introduced this year, "will hardly affect the palettes of perfumers," states IFRA Director General Jean-Pierre Houri in a June 2 release. Rumors that the upcoming version of the amendment includes new policies on furocoumarins or methyleugenol (an essential component of the smell of roses) are simply "wrong," he says, noting there are only seven changes to the amendment overall. "Previous years have seen quite heavy amendments due to the change over to our new Quantitative Risk Assessment approach," Houri says. "However, this is nearly complete and is reflected in this year's very light amendment." IFRA's Research Institute for Fragrance Materials has bumped heads with industry representatives and European scientific authorities previously regarding its increasingly refined QRA (1"The Rose Sheet" Oct. 27, 2008)
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.